B
Biobank
A large collection of biological samples (like blood or saliva) and the health information that goes with them, gathered from many volunteers so researchers can study how genes and biology relate to disease over time.
See also:
Generation Scotland
Biomarker
A measurable signal in the body — a protein, a molecule, a genetic variant — that tells you something about a condition: who is likely to develop it, how it will progress, or which treatment will work.
See also:
Omics
Bitfount
The federated analysis software OPP uses to run research queries inside secure data environments. It lets a researcher's question travel to the data instead of the data travelling to the researcher.
See also:
Federated analysis
D
Data Access Committee
The independent group that reviews and approves requests to run analyses through FedOMICS. OPP has two layers of this oversight: a project-wide committee plus each data custodian's own committee.
See also:
Data custodian
Data custodian
The organisation legally responsible for a dataset — for example Generation Scotland, or an NHS trust holding patient records. Nothing happens to that data without the custodian's agreement.
See also:
Trusted Research Environment (TRE)
Data federation
An approach to combining insight from datasets held in different places without moving or pooling the underlying data itself. Analysis runs locally at each site; only summary results travel.
See also:
Federated analysis
Drug repurposing
Finding a new use for a medicine that's already approved for a different condition — faster and cheaper than developing a drug from scratch, because its safety is already established.
See also:
Drug target
Drug target
A specific gene, protein, or biological pathway that a medicine could act on to treat a disease. Identifying strong drug targets is a key step before any new treatment can be developed.
See also:
Open Targets Platform
Missing a term, or think a definition could be clearer? We write these with people with lived experience — suggest a term.